COVID-19 may have accelerated the adoption of RBQM, but it is the intrinsic benefits that are cementing its continued use.
Patrick Hughes
Advertisement
Patrick Hughes is Co-Founder, Chief Commercial Officer, CluePoints
Articles by Patrick Hughes
Applied Clinical Trials
What started as an initiative called Risk-Based Monitoring several years ago is now evolving into Risk-Based Quality Management of clinical trials with a much wider impact to the pharma industry.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Comparing OpenAI and Mistral on Clinical Trial Matching
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Why Outdated Perceptions of APAC Clinical Trial Sites Persist Among Smaller Biotechs
4
Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health
5